ABL BIOTEC A/S: Financial statements 2013
CVR: 50811018
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -96,915 and a net result of DKK 2,724,804 compared with DKK 3,685,841 the year before. Equity in the 2013 report amounted to DKK 22,438,251. The solvency ratio was 99.3%.
- Gross Profit
- DKK -96,915
- Profit/Loss
- DKK 2,724,804
- Equity
- DKK 22,438,251
- Total Assets
- DKK 22,590,087
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -97 t. | 2.7 mio. | 22.4 mio. | - |
| 2012 | - | -51 t. | 3.7 mio. | 21.5 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ABL BIOTEC A/S has published its annual report for 2012. Gross profit came to DKK -50,503, and the net result was DKK 3,685,841.
As of January 1, 2013, MJAKP P/S has been appointed auditor of ABL BIOTEC A/S.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.